Updates
Regular updates related to sourcing and the management of health products are available on this page.
-
05 November 2021
Placing Orders and Procuring Health Products for 2022
While the Global Fund’s assessment of health product supply disruption has been moderate overall during the past 18 months, supply challenges are increasing as a result of growing international freight capacity constraints. Those challenges are likel... -
20 September 2021
Opportunity for Evaluation of Diagnostic Products
-
31 August 2021
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). -
21 June 2021
Updated Guide to Global Fund Policies on Procurement and Supply Management of Health Products
-
The Global Fund continues to support countries to process requisitions efficiently and ensure products for the three diseases and COVID-19 are delivered as close to the promised dates as possible.
-
-
-
18 September 2020
COVID-19 Response: Procurement of Automated Polymerase Chain Reaction Diagnostic Tests
The Global Fund is working with partners to rapidly and equitably support access to COVID-19 health products and diagnostics for low- and middle-income countries by following the World Health Organization’s allocation model. -
15 September 2020
COVID-19 Response: Antigen-Detection Diagnostic Test Procurement
Following the World Health Organization’s interim guidance on antigen-detection in the diagnosis of COVID-19 from 11 September, the Global Fund anticipates being able to support countries in accessing high-performing antigen-detecting rapid diagnost... -
08 September 2020
COVID-19 Response: Corticosteroids Procurement
Following the World Health Organization guidance Corticosteroids for COVID-19 from 2 September, the Global Fund has confirmed that corticosteroids can be funded through Global Fund grants. -
The Global Fund has opened a new channel through wambo.org, the Global Fund’s procurement tool, for Principal Recipients to access quality-assured health products including personal protective equipment as part of their response to COVID-19 and consi...
-
The Global Fund continues to work closely with our technical partners, especially the Stop TB Partnership's Global Drug Facility and our procurement service agents, as the global response to the COVID-19 pandemic evolves.
-
14 April 2020
COVID-19 Response: Impact on Health Product Supply
The Global Fund's product and delivery outlook shows the overall impact of COVID-19 on health product supply chains for Global Fund grants remains at moderate. -
07 April 2020
COVID-19 Response: Impact on Health Product Supply
The Global Fund’s product and delivery outlook shows the overall impact of COVID-19 on health product supply chains for Global Fund grants remains at moderate. -
The Global Fund’s product and delivery outlook shows the overall impact of COVID-19 on health product supply chains for Global Fund grants has increased from "low to moderate" to "moderate."
-
The COVID-19 pandemic is impacting global health product supply chains, affecting key materials and ingredients, finished health products, logistics, shipping and more.
-
The global response to control the outbreak of the new coronavirus, COVID-19, may influence health product supply chains, including logistics and shipping, as almost all finished health products or ingredients used in health products originate from C...
-
11 November 2019
Opportunity for Evaluation of Diagnostic Products
-
31 October 2019
Opportunity for Evaluation of Diagnostic Products
-
03 July 2019
Opportunity for Evaluation of Diagnostic Products